UCB Investor

You see, UCB wants to be a world leader when it comes to treating ailments related to the immune and central nervous systems (CNS).
Technology: AgeTech Companies
Industry: AI
Headquarters: Brussels, Brussels Hoofdstedelijk Gewest, Belgium
Founded Date: 1928-01-01
Employees Number: 10001+
Funding Status: Public
Investment Stage: Early Stage Venture
Number Of Exits: 3
Acquisitions Number: Made Acquisitions
Investors Number: 8
Total Funding: 202213820
Estimated Revenue: $1B to $10B
Last Funding Date: 2022-05-24
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership